Clinical Trials Directory

Trials / Completed

CompletedNCT04997876

Diagnostic Reliability of OCT Biomarkers for iERM

Diagnostic Reliability of OCT Biomarkers for Idiopathic Epiretinal Membranes

Status
Completed
Phase
Study type
Observational
Enrollment
136 (actual)
Sponsor
Vienna Institute for Research in Ocular Surgery · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Several optical coherence tomography (OCT) biomarkers with potential to influence postsurgical outcomes after vitrectomy with membrane peeling for idiopathic epiretinal membranes (iERM) have been described in single predictor analyses in the past. Aim of the study is to assess the reliability of diagnosis of OCT biomarkers and to calculate their impact on postsurgical visual acuity in a multiple regression analysis.

Detailed description

Several optical coherence tomography (OCT) biomarkers with potential to influence postsurgical outcomes after vitrectomy with membrane peeling for idiopathic epiretinal membranes (iERM) have been described in single predictor analyses in the past. A recent multifactorial analysis outlined macular thickness and DRIL to be significant predictors for postsurgical visual acuity (Karasavviodou et al.). Nevertheless, reliability of diagnosing OCT biomarkes among patients with iERM was not yet assessed, to our knowledge. Aim of the study is to assess the reliability of diagnosis of OCT biomarkers and to calculate their impact on postsurgical visual acuity in a multiple regression analysis.

Conditions

Interventions

TypeNameDescription
OTHERBiomarker analysisBiomarkers from presurgical OCTs are assessed

Timeline

Start date
2021-01-11
Primary completion
2021-08-05
Completion
2021-08-21
First posted
2021-08-10
Last updated
2021-08-24

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT04997876. Inclusion in this directory is not an endorsement.